Amanote Research
Register
Sign In
565. Feasibility and Effectiveness of Exon 51 Skipping in Human-Like MDX Mutation
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)38006-6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
Antisense-Induced Exon Skipping and Synthesis of Dystrophin in the MDX Mouse
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Polyquaternium-Mediated Delivery of Morpholino Oligonucleotides for Exon-Skipping in Vitro and in MDX Mice
Drug Delivery
Medicine
Pharmaceutical Science
Proteomic Profiling of Antisense-Induced Exon Skipping Reveals Reversal of Pathobiochemical Abnormalities in Dystrophic MDX Diaphragm
Proteomics
Biochemistry
Molecular Biology
The Silent Mutation Nucleotide 744 G → A, Lys172Lys, in Exon 6 of BRCA2 Results in Exon Skipping
Breast Cancer Research and Treatment
Cancer Research
Oncology
Ab Initio Prediction of Mutation-Induced Cryptic Splice-Site Activation and Exon Skipping
European Journal of Human Genetics
Genetics
Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells
PLoS ONE
Multidisciplinary
Thousands of Exon Skipping Events Differentiate Among Splicing Patterns in Sixteen Human Tissues
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Autoregulation of the Human Splice Factor Kinase CLK1 Through Exon Skipping and Intron Retention
Gene
Medicine
Genetics
A Multicenter Comparison of Quantification Methods for Antisense Oligonucleotide-Induced DMD Exon 51 Skipping in Duchenne Muscular Dystrophy Cell Cultures
PLoS ONE
Multidisciplinary
